KAHR MedicalKAHR Medical
KAHR Medical

KAHR Medical

Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer.

2011Active50

About

KAHR Medical is a biopharmaceutical company focused on developing a novel drug platform of immunotherapeutic bi-functional fusion proteins. These innovative therapies are designed to leverage the human immune system to target multiple cancer indications, offering a new approach to cancer treatment.

Technology stack

detected 2026-06-14
Est. monthly stack spend~$350/mo
EmailMicrosoft 365
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does KAHR Medical do?

KAHR Medical is a biopharmaceutical company focused on developing a novel drug platform of immunotherapeutic bi-functional fusion proteins. These innovative therapies are designed to leverage the human immune system to target multiple cancer indications, offering a new approach to cancer treatment.

How much funding has KAHR Medical raised?

KAHR Medical has raised a total of $10M in funding. The most recent round on record is Seed.

Where is KAHR Medical headquartered?

KAHR Medical is headquartered in Jerusalem, Israel.

When was KAHR Medical founded?

KAHR Medical was founded in 2011.

What industry does KAHR Medical operate in?

KAHR Medical operates in Healthcare, Biotech, MedTech, HealthTech, Drug Discovery, Immunotherapy.

How many employees does KAHR Medical have?

KAHR Medical has approximately 50 people on record.